News >

Chemoimmunotherapy Role in CLL Shifting With Rise of Novel Agents

Jessica Hergert
Published: Wednesday, Dec 04, 2019

Jonathon B. Cohen, MD

Jonathon B. Cohen, MD

The introduction of novel and oral therapeutics has revolutionized chronic lymphocytic leukemia (CLL) management, and has also diminished the role for chemoimmunotherapy for both patients with newly diagnosed and relapsed/refractory disease, said Jonathon B. Cohen, MD, MS.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication